tirzepatide cirrhosis in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: a novel star on the horizon? Advances in the Management of
Description
But the more rapid and significant the weight loss, the less likely skin will fully tighten without targeted support

10.1111/sms.13567 [EL 2
Other side effects Very common (may affect more than 1 in 10 people) feeling sick (nausea) this usually goes away over time diarrhoea this usually goes away over time Common (may affect up to 1 in 10 people) being sick (vomiting) low blood sugar (hypoglycaemia) when this medicine is used with another antidiabetic medicine The warning signs of low blood sugar may come on suddenly
00070-5/asset/741f55c5-19b9-466e-8fd6-b3c5fb427911/main.assets/gr2_lrg.jpg)
Other GLP-1 RAs may use different peptides, such as liraglutide or tirzepatide

No loss in weeks 12 is common and normal

Are there downsides
